BIOMAT Database Logo BIOMAT Database Logo

cis-Platinum-hexamethylmelamine therapy of advanced ovarian cancer. 1981

J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006585 Altretamine A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine. Hemel,Hexamethylmelamine,Hexalen,Hexastat,Hexinawas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines

Related Publications

J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
Combination chemotherapy of advanced ovarian cancer with hexamethylmelamine, cis-Platinum, and doxorubicin after failure of prior therapy.
November 1980, Obstetrics and gynecology,
J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
cis-Platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma.
January 1983, Cancer chemotherapy and pharmacology,
J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
Single-agent cis-platinum therapy for advanced ovarian cancer.
October 1981, Obstetrics and gynecology,
J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
Treatment of ovarian cancer with a combination of cis-platinum, adriamycin, cyclophosphamide and hexamethylmelamine.
January 1982, Oncology,
J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.
January 1986, Oncology,
J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer.
April 1983, Gynecologic oncology,
J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
Adriamycin and cis-platinum in advanced ovarian cancer.
June 1985, European journal of cancer & clinical oncology,
J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
Hexamethylmelamine in platinum-resistant ovarian cancer: how active?
December 1992, Gynecologic oncology,
J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
Combined cyclophosphamide, adriamycin and cis-platinum in advanced ovarian cancer resistant to chlorambucil and cis-platinum.
June 1985, Gynecologic oncology,
J A Lopez, and J G Krikorian, and S F Dias, and A S Spiers, and H E Finkel, and D E Barnard
Hexamethylmelamine, methotrexate and 5-fluorouracil (HMF) for progressive ovarian carcinoma during therapy with cis-platinum, cyclophosphamide +/- doxorubicin.
October 1985, Gynecologic oncology,
Copied contents to your clipboard!